Selarsdi on HealthSpring Assurance Rx (S5617-118)
ustekinumab-aekn
Covered, with prior authorization required.
Tier 3 (preferred brand). Quantity limit of 0.5 per 28 days.
$537.22
Patient pays / month, after deductible
$998.47
Patient pays / month, before the $615.00 deductible
$1,611.65
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
SELARSDI 45 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $2,148.87 for a month. Other covered strengths are listed below.
Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| SELARSDI 45 mg/.5mL Injection, Solution | 3 | $537.22 | PA · 0.5 per 28 days |
| SELARSDI 45 mg/.5mL Injection, Solution | 3 | $537.22 | PA · 0.5 per 28 days |
| SELARSDI 90 mg/mL Injection, Solution | 5 | $994.85 | PA · 1 per 28 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5617-118